Max Healthcare Institute Limited has informed the Exchange about construction of Phase-I of Max Super Specialty Hospital, Shaheed Path, Lucknow
MAXHEALTH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 6.7 pts less than Nifty 100 and 6.7 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Max Healthcare reported strong FY2026 consolidated results with revenue from operations growing 19.1% to ₹8,37,345 lakhs from ₹7,02,846 lakhs. Profit after tax surged 34.1% to ₹1,44,241 lakhs from ₹1,07,588 lakhs, with annualized EPS of ₹14.83 versus ₹11.07 in the prior year. The Board recommended a dividend of ₹2 per equity share (20% on ₹10 face value). Key business approvals include construction of Phase-I of Max Super Specialty Hospital at Shaheed Path, Lucknow with ~712 beds capacity, shifting registered office from Mumbai to Gurugram, and re-classification of Radiant Life Care Hospital Foundation from Promoter Group to Public category. The company also completed acquisition of 58.28% stake in Kalinga Hospitals Limited for ₹29,797 lakhs. Statutory auditors S.R. Batliboi & Co. LLP issued an unmodified (clean) opinion on the financial results.
Strong profit growth of 34% and clean audit opinion are positive signals for shareholders. The new hospital construction in Lucknow and recent Kalinga acquisition indicate expansion plans that could drive future revenue growth. The dividend announcement provides immediate shareholder returns.